XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Net income $ 8,397 $ 8,212
Adjustments to reconcile net income to net cash from operating activities    
Provision for credit losses 1,399 2,108
Depreciation, amortization and accretion 2,835 3,358
Compensation expense related to stock options and restricted stock awards 395 654
Change in cash surrender value of BOLI (240) (221)
Gain on sale of loans held for sale (1,838) (1,476)
Gain on sale of MSRs (8,215) 0
Loss on sale of investment securities 7,998 0
Origination of loans held for sale (109,554) (73,050)
Proceeds from sale of loans held for sale 94,874 78,316
Impairment of MSRs 93 2
Changes in operating assets and liabilities    
Accrued interest receivable (450) (662)
Other assets (496) (470)
Other liabilities 5,079 1,700
Net cash from operating activities 277 18,471
CASH FLOWS FROM INVESTING ACTIVITIES    
Proceeds from sale of investment securities 44,036 0
Maturities, prepayments, and calls 4,293 2,497
Purchases (38,009) 0
Maturities of certificates of deposit at other financial institutions 1,925 0
Purchase of certificates of deposit at other financial institutions (980) 0
Portfolio loan originations and principal collections, net (8,226) (55,269)
Net cash from acquisitions 0 336,157
Proceeds from sale of mortgage servicing rights 16,168 0
Purchase of portfolio loans (15,492) (829)
Purchase of premises and equipment (357) (954)
Change in FHLB stock, net (795) 6,748
Net cash from investing activities 2,563 288,350
CASH FLOWS USED BY FINANCING ACTIVITIES    
Net decrease in deposits (57,083) (109,439)
Proceeds from borrowings 175,000 382,500
Repayments of borrowings (138,806) (561,500)
Dividends paid on common stock (2,031) (1,935)
(Disbursements) proceeds from stock options exercised, net (507) 42
Common stock repurchased for employee/director taxes paid on restricted stock awards 0 (16)
Issuance of common stock - employee stock purchase plan 302 271
Net cash used by financing activities (23,125) (290,077)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (20,285) 16,744
CASH AND CASH EQUIVALENTS, beginning of period 65,691 41,437
CASH AND CASH EQUIVALENTS, end of period 45,406 58,181
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION    
Interest on deposits and borrowings 12,087 7,064
Income taxes 0 0
SUPPLEMENTARY DISCLOSURES OF NONCASH OPERATING, INVESTING AND FINANCING ACTIVITIES    
Change in fair value on available-for-sale investment securities 5,446 6,136
Change in fair value on fair value and cash flow hedges 3,324 (2,424)
Change in fair value on portfolio loans measured under the fair value option 2 577
Retention in gross MSRs from loan sales 576 405
ROU assets in exchange for lease liabilities 0 1,574
Acquisitions:    
Assets acquired 0 87,512
Liabilities assumed $ 0 $ 424,949